Safety of bevacizumab treatment in combination with standard chemotherapy for metastatic colorectal cancer : a retrospective review of 65 Japanese patients
スポンサーリンク
概要
- 論文の詳細を見る
- 2009-12-01
著者
-
ONOZAWA Yusuke
Division of Oncology and Hematology, National Cancer Center Hospital East
-
BOKU NARIKAZU
Divison of Gastrointestinal Oncology, Shizuoka Cancer Center
-
FUKUTOMI AKIRA
Divison of Gastrointestinal Oncology, Shizuoka Cancer Center
-
HIRONAKA SHUICHI
Divison of Gastrointestinal Oncology, Shizuoka Cancer Center
-
YASUI HIROFUMI
Divison of Gastrointestinal Oncology, Shizuoka Cancer Center
-
YAMAZAKI KENTARO
Divison of Gastrointestinal Oncology, Shizuoka Cancer Center
-
TAKU KEISEI
Divison of Gastrointestinal Oncology, Shizuoka Cancer Center
-
Boku Narikazu
Division Of Digestive Endoscopy And Gastrointestinal Oncology National Cancer Center Hospital East
-
Yamazaki Kentaro
Division Of Gastrointestinal Oncology Shizuoka Cancer Center
-
Taku Keisei
Divison Of Gastrointestinal Oncology Shizuoka Cancer Center
-
Fukutomi Akira
Division Of Gastrointestinal Oncology Shizuoka Cancer Center
-
Yasui Hirofumi
Division Of Gastrointestinal Oncology Shizuoka Cancer Center
-
Yasui Hirofumi
Division Of Gastroenterology Shiga University Of Medical Science
-
TAMIYA Akihiro
Division of Thoracic Oncology, Shizuoka Cancer Center
-
Tamiya Akihiro
Division Of Gastrointestinal Oncology Shizuoka Cancer Center
-
Onozawa Yusuke
Division Of Gastrointestinal Oncology Shizuoka Cancer Center
-
Taku Keisei
Division Of Gastrointestinal Oncology Shizuoka Cancer Center
-
MACHIDA Nozomu
Division of Gastrointestinal Oncology, Shizuoka Cancer Center
-
KOJIMA Takashi
Division of Gastrointestinal Oncology, Shizuoka Cancer Center
-
Machida Nozomu
Division Of Gastrointestinal Oncology Shizuoka Cancer Center
-
Hironaka Shuichi
Division Of Gastrointestinal Oncology Shizuoka Cancer Center
-
Boku Narikazu
Division Of Gastrointestinal Oncology Shizuoka Cancer Center Hospital
-
Kojima Takashi
Division Of Gastrointestinal Oncology Shizuoka Cancer Center
-
Yamazaki Kentaro
Division Of Gastrointestinal Oncology And Endoscopy Shizuoka Cancer Center
関連論文
- Treatment for Locally Advanced Esophageal Carcinoma Complicated by Fistulas: Case Report
- Treatable Subsets in Cancer of Unknown Primary Origin
- Results of a retrospective analysis of gemcitabine as a second-line treatment after chemoradiotherapy and maintenance chemotherapy using 5-fluorouracil in patients with locally advanced pancreatic cancer
- A retrospective study of second-line chemotherapy for unresectable or recurrent squamous cell carcinoma of the esophagus refractory to chemotherapy with 5-fluorouracil plus platinum
- Macroscopic typing with wall stricture sign may reflect tumor behaviors of advanced colorectal cancers
- Correlation Between the Depth of Invasion and Hardness of Resected Gastric Carcinoma Specimens Using a New Ultrasound Tactile Sensor
- Small cell carcinoma of the esophagus responding to fourth-line chemotherapy with weekly paclitaxel
- Expression of Integrin α3 in Gastric and Colorectal Cancers : Its Relation to Wall Contraction and Mode of Invasion
- Comparison of chemotherapy regimens for concurrent chemoradiotherapy in unresectable stage III non-small cell lung cancer
- Evaluation of S-1 as third- or further-line chemotherapy in advanced non-small-cell lung cancer
- Butyrate blocks interferon-γ-inducible protein-10 release in human intestinal subepithelial myofibroblasts
- Matrix metalloproteinase-3 secretion from human colonic subepithelial myofibroblasts : role of interleukin-17
- ENDOSCOPIC MUCOSAL RESECTION FOR EARLY ADENOCARCINOMA ARISING IN BARRETT'S ESOPHAGUS
- Response of the Primary Lesion in Gastric Cancer to Chemotherapeutic Trials
- Small-cell carcinoma in the common bile duct treated with multidisciplinary management
- Safety of bevacizumab treatment in combination with standard chemotherapy for metastatic colorectal cancer : a retrospective review of 65 Japanese patients
- Chemotherapy for metastatic disease : review from JCOG trials
- Comparison of combination chemotherapy with irinotecan and cisplatin regimen administered every 2 or 4 weeks in pretreated patients with unresectable or recurrent gastric cancer : retrospective analysis
- Chemotherapy for metastatic gastric cancer in Japan
- OPTIMAL TIMING OF ENDOSCOPIC EVALUATION OF THE PRIMARY SITE OF ESOPHAGEAL CANCER AFTER CHEMORADIOTHERAPY OR RADIOTHERAPY : A RETROSPECTIVE ANALYSIS
- Occurrence and Clinical Features of Brain Metastasis after Chemoradiotherapy for Esophageal Carcinoma
- Risk factors and clinical courses of chemoradiation-related arterio-esophageal fistula in esophageal cancer patients with clinical invasion of the aorta
- Genotype-directed, dose-finding study of irinotecan in cancer patients with UGT1A1^*28 and/or UGT1A1^*6 polymorphisms
- Leptomeningeal carcinomatosis associated with gastric cancer
- Adjuvant therapy with imatinib mesylate after resection of primary high-risk gastrointestinal stromal tumors in Japanese patients